F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, review of late medication reports, staff interview, and policy review, the facility failed to ensure
medications administered in a timely manner as ordered. This affected three (Residents #1, #4, and #43) of
four residents reviewed for late medications. The facility census was 49.
Findings include:
1. Review of the medical record for Resident #1 revealed an admission date of 02/21/21 with diagnoses
including but not limited to frontal lobe and executive function deficit following nontraumatic intracerebral
hemorrhage, normal pressure hydrocephalus, cognitive communication deficit, cardiac arrhythmia, epilepsy,
heart failure, anxiety, and major depressive disorder.
Review of The Minimum Data Set (MDS) assessment dated [DATE] revealed Resident #1 was rarely
understood. Resident #1 required maximum assistance to total dependence on staff for activities of daily
living.
Review of the late medication report for 03/05/24 revealed the following medications were due between
7:00 A.M. and 10:00 A.M. losartan potassium (heart) 50 milligrams (mg), multiple vitamin, lactulose 10
grams (gm)/15 milliliter (ml) 10 ml for constipation, escitalopram 10 mg (depression), ferrous sulfate 325
mg, aspirin 81 mg, depakote delayed release (behaviors) 250 mg, vitamin D3 50 micrograms (mcg), and
house supplement were administered at 12:58 P.M.
Review of the late medication report for 03/06/24 revealed following medications were due between 7:00
A.M. and 10:00 A.M. losartan potassium (heart) 50 milligrams (mg), multiple vitamin, lactulose 10 grams
(gm)/15 milliliter (ml) 10 ml for constipation, escitalopram 10 mg (depression), ferrous sulfate 325 mg,
aspirin 81 mg, depakote delayed release (behaviors) 250 mg, vitamin D3 50 micrograms (mcg), and house
supplement were administered at 12:25 P.M.
2. Review of the medical record for Resident #4 revealed an admission date of 01/06/21 with diagnoses
including but not limited to unspecified foreign body in the bronchus causing other injury, dysphagia,
depression, personal history of malignant neoplasm of bladder, umbilical hernia, diverticulitis, and
hypertension.
Review of the MDS assessment dated [DATE] revealed Resident #4 was moderately cognitively impaired.
Resident #4 required substantial/maximal assistance for activities of daily living.
Review of the late medication report for 03/05/24 revealed the following medications were due
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
366312
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366312
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/07/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Gardens of St. Francis
930 South Wynn Road
Oregon, OH 43616
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
between 7:00 A.M. and 10:00 A.M. potassium chloride extended release 20 milliequivalent (MEQ), senna
8.6 mg (constipation), lasix 40 mg (water pill), ocuvite-lutein capsule, oyster-cal 500 mg, aspirin 325 mg,
amlodipine besey-benazeprile capsule 10/20 mg (blood pressure), and celexa 20 mg (depression) were
given at 11:13 A.M.
3. Review of the medical record for Resident #43 revealed an admission date of 02/02/21 with diagnoses
including but not limited to heart failure, unspecified convulsions, type two diabetes, coronary artery
disease, dementia, anxiety, and hypertension.
Review of the MDS assessment dated [DATE] revealed Resident #13 was cognitively intact. Resident #43
required supervision/touching assistance for activities of daily living.
Review of physician orders for Resident #43 revealed an order for Carvedilol 6.25 mg twice daily at 8:00
A.M. and 5:00 P.M.
Review of the late medication report for Resident #43 revealed on 03/04/24 carvedilol 6.25 mg was
administered at 10:30 A.M.
Review of the late medication report for Resident #43 revealed on 03/05/24 the following medications
scheduled between 7:00 A.M. and 10:00 A.M. ferrous sulfate 325 mg, multivitamin with minerals, claritin 10
mg (allergies), plavix 75 mg (blood thinner), omeprazole 20 mg (stomach), gabapentin 100 mg
(neuropathy), rexulti 0.5 mg (mood), klonopin 0.5 mg (anxiety), keppra 500 mg (seizures), sertraline 100
mg (depression) were administered at 1:02 P.M.
Review of the late medication report for Resident #43 revealed on 03/06/24 carvedilol 6.25 mg was
administered at 9:13 A.M. and the 5:00 P.M. dose was administered at 6:12 P.M.
Observation on 03/07/24 at 9:21 A.M. revealed Licensed Practical Nurse (LPN) #647 administering
carvedilol 6.25 mg (heart) to Resident #43 at 9:21 A.M. and the medication was ordered for 8:00 A.M.
Interview on 03/07/24 at 9:24 A.M. LPN #647 verified Resident #43's carvedilol 6.25 mg was to be
administered at 8:00 A.M. and was administered late.
Interview on 03/07/24 at 2:55 P.M. with the Director of Nursing (DON) verified there were late medication
reports showing late medication administration for Residents #1, #4, and #43. The DON stated she believed
the medications were given on time but the nurses were not signing them out as they were administered,
however the DON verified there was no evidence to support medications were administered on time.
Review of policy titled, Medication Administration, revised 05/03/22 revealed medications would be
administered within 60 minutes prior to or after scheduled time unless otherwise ordered by physician.
This deficiency represents non-compliance investigated under Complaint Number OH00150807 and is an
example of continued noncompliance from the survey dated 02/01/24.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366312
If continuation sheet
Page 2 of 2